Botulinum Toxin Therapy for Psychiatric Disorders in Clinical Practice: A Retrospective Case Study

Botulinum Toxin Therapy for Psychiatric Disorders in Clinical Practice: A Retrospective Case Study

Inhibiting the facial expression of negative emotions via botulinum toxin A (BTX) has been shown to mitigate symptoms of clinical depression in randomized controlled trials. This retrospective case study sought to reproduce the beneficial effects of BTX in a naturalistic setting for major depressive...

Full description

Bibliographic Details
Main Authors: Franziska Lehnert, Insa Neumann, Tillmann H. C. Krüger, Marc A. Wollmer
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Toxins
Subjects:
botulinum toxin
depression
anxiety
mental disorder
psychiatry
outpatient
Online Access:https://www.mdpi.com/2072-6651/15/6/385

Internet

https://www.mdpi.com/2072-6651/15/6/385

Similar Items